Certificate of analysis
A certificate of analysis (COA) is a formal laboratory-prepared document that details the results of (and sometimes the specifications and analytical methods for) one or more laboratory analyses, signed—manually or electronically—by an authorized representative of the entity conducting the analyses. This document gives assurances to the recipient that the analyzed item is what it is designated to be, or has the features advertised by the producer. The design and content of a COA may be based upon a set of requirements identified by the lab, by regulatory-driven requirements, and/or by standards developed by standard developing organizations. The COA is used in a wide variety of industries, including but not limited to the agriculture, chemical, clinical research, food and beverage, and pharmaceutical industries.
Use in various industries
The COA is typically used in industries where the quality of a produced good is of significant importance and the COA recipient needs assurances of that quality. By extension, this often means regulations, standards, and/or guidelines are in place to better ensure analyses are approved and reported correctly. For example, regulations, standards, and/or guidelines affect COA use in agriculture, chemical, clinical research, food and beverage, and pharmaceutical industries. The COA may be used as a certification of product quality, an identification document, or a comparison document, depending upon the context.
A certificate of analysis can be associated with cannabis and cannabis-derived products, attesting to their laboratory analysis for cannabinoids, adulterants, heavy metals, pesticides, mold, etc. This gives consumers "an easy way to review test results from responsible companies selling cannabis and cannabis-infused products".
In the United States, as of September 2022[update], the regulatory mandate for requiring a COA is driven by state law, which can vary significantly. States like California and Maine lay out clear regulations concerning how cannabis and cannabis products are reported on a COA. Other states may not regulate COAs. Additionally, products containing cannabidiol (CBD), a non-psychoactive constituent of cannabis that is capable of being extracted from hemp, are not mandated to have a corresponding COA by the U.S. government, though some states like Indiana require a COA for CBD, along with a scannable QR code.
Contents and delivery of a COA
As regulations across counties, states, territories, countries, and supranational unions can vary, the contents and delivery/inclusion mechanisms for COAs will vary. Broadly speaking, however, the following represent elements that may be common to a COA:
- the demographics and other identifiers for the supplier of the product/material/sample
- the demographics and license information for the laboratory conducting the analyses
- the demographics or details of any ancillary entities associated with the tested product (e.g., distributor or cultivator, as with cannabis products)
- a clear description of the identity of the product/material/sample
- a clear identifier of what type of testing was performed (e.g., "regulatory compliance testing")
- any associated batch numbers, sample numbers, etc.
- a chain of custody of the product/sample being tested, including dates, times, and relevant photos
- the weight or unit count of the product/material/sample
- the quality and concentration of the product/material/sample
- the analytical methods (standard and non-standard), analytical instrumentation, and specifications (e.g., limits of detection and quantitation)
- the analytical results, dated and presented in "a uniform, accurate, and concise manner", with a clear indication of passing or failing, when applicable
- a key for abbreviations/initialisms and what they mean
- the signature of the authorized person who performed or approved the analysis, as well as contact information and qualifications
- the initials or signature of the authorized person who corrected the COA (if permitted), plus a clear identifier indicating the COA is corrected
In the case of a produced chemical, drug, ingredient, or standard, the manufacturer will likely include a COA for the end user. In the case of a tested product/material/sample, the recipient of the COA will be the entity that ordered the analysis or mandated the test via regulation, as with cannabis testing. If a regulatory body mandated the test, they will designate how the results should be delivered, whether physically or electronically. In the case of cannabis testing, electronic upload to a track and trace system may be mandated.
- Manawis, R. (6 May 2022). "A Short Guide on Certificate of Analysis". SafetyCulture. Retrieved 26 September 2022.
- "7 CFR § 91.25 - Certificate requirements". Legal Information Institute. Cornell Law School. 6 April 2010. Retrieved 26 September 2022.
- "2014 Quality Assurance/Quality Control Guidelines for Feed Laboratories, Section 2". Association of American Feed Control Officials. 2014. Retrieved 26 September 2022.
- "ABFT Forensic Toxicology Laboratory Accreditation Manual" (PDF). American Board of Forensic Toxicology. 1 November 2013. p. 18. Retrieved 26 September 2022.
- "TSCA Stakeholders Beware: Enforcement Is on the Rise". Regulatory Developments. Bergeson & Campbell PC. 11 February 2020. Retrieved 26 September 2022.
- "Guidelines for Clinical Trials in Human Subjects" (PDF). Ministry of Health, Pharmaceutical Administration. January 2006. p. 18. Retrieved 26 September 2022.
- Committee for Medicinal Products for Human Use (20 September 2017). "Guideline on the requirements for the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials" (PDF). European Medicines Agency. p. 13. Retrieved 26 September 2022.
- "Laboratory Approval Program – General Policies & Procedures" (PDF). U.S. Department of Agriculture. 16 November 2018. Retrieved 26 September 2022.
- U.S. Food and Drug Administration (3 December 2021). "86 FR 68728, Laboratory Accreditation for Analyses of Foods". Federal Register. Retrieved 26 September 2022.
- "Guidance for Industry, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients". U.S. Food and Drug Administration. 9 August 2018. Retrieved 26 September 2022.
- WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting (2014). "Series #986, Annex 2: WHO good manufacturing practices for pharmaceutical products: main principles". WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth report (PDF). World Health Organization. Geneva, Switzerland: World Health Organization. p. 133. ISBN 978-92-4-069254-1. OCLC 897446262.
- Vogel, Ashley (2018). "Commercial cultivation of cannabis". In Wedman-St.Louis, Betty (ed.). Cannabis: A Clinician's Guide. CRC Press. ISBN 978-1351398039. OCLC 1031313425.
- "Cal. Code Regs. tit. 4 § 15726 - Certificate of Analysis (COA)". Casetext. 16 September 2022. Retrieved 26 September 2022.
- Maine Department of Administrative and Financial Services (8 September 2022). "Rules for the Certification of Cannabis Testing Facilities" (PDF). Code of Maine Rules. Retrieved 27 September 2022.
- Gill, L.; Wheeler, E. (5 February 2020). Podcast: Understanding CBD. Consumer Reports. Event occurs at 23:15. Retrieved 27 September 2022.
- Kent, M. (20 November 2020). "What is a CBD Certificate of Analysis (and Why Should You Care)?". CBD Choice. Retrieved 27 September 2022.
- Shortt, D. (14 July 2018). "Labeling CBD Products: The Unique Case of Indiana". Canna Law Blog. Harris Bricken Law Group. Archived from the original on 29 April 2020. Retrieved 27 September 2022.
This article is a direct transclusion of the Wikipedia article and therefore may not meet the same editing standards as CannabisQAwiki.